2SchleusenerJT, Tazelaar HD, Jung SH, et al . Neuroendocrine differentiation is an independent prognostic factor in chemotheraphy-treated nonsmall cell lung carcinoma [J].Cancer, 1996, 77(7): 1284-1291.
3Kim YS, Kondziolka, Flickinger JC, et al. Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain [J]. Cancer, 1997, 80(11): 2075-2083.
4Farnell GF, Bucker JC, Cascino TL, et al. Brain metastases from colorectal carcinoma [J]. Cancer, 1996, 78(4): 711-716.
5Arbit E, Wronski M, burt M, et al. The Treatment of patients with recurrent brain metastases [J]. Cancer, 1995, 76(5): 765-773.
6Nguyen LN, Maor MH, Oswald M J, et al . Brain metastases as the only manifestation of an undetected primary tumor[J]. Cancer, 1998, 83(10): 2181-2184.
7Bindal AK, Bindal RK, Hess KR, et al. Surgery versus radiosurgery in the treatment of brain metastasis [J]. Neurosurgery, 1996, 84(5): 748-754.
8Boogerd W, Dalesio O, Bais E, et al . Response of Brain Metastases From Breast Cancer to systemic chemotheraphy[J]. Cancer, 1992, 69((4): 972-980.
